TARS
Tarsus Pharmaceuticals, Inc.
Price:
42.98
USD
Volume:
324,236
United States | Pharmaceuticals
TARS Gross Margin
As of 2025-05-25, the Gross Margin of Tarsus Pharmaceuticals Inc (TARS) is 93%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
TARS Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 93% |
| 2023-12-31 | 90.9% |
| 2022-12-31 | 96.3% |
| 2021-12-31 | 96.4% |
| 2020-12-31 | - |
| 2019-12-31 | - |
| 2018-12-31 | - |
| - | |
| - | |
| - |
TARS Gross Margin - Peers Comparison